Beta The Briev beta is out. Free on iPhone via TestFlight — install it in under a minute.

Join the beta ↗
Briev
Live
Health

Midlife brain shift replaces protective cells with inflammatory ones, raising dementia risk

Researchers found that around age 50 the brain’s resident immune cells are increasingly swapped for blood-derived inflammatory cells, a change that may heighten vulnerability to neurodegeneration.

Analysis of postmortem hippocampal samples from 40 neurologically normal donors spanning ages 20 to 95 showed that the brain’s native immune cells, microglia, begin to be supplanted by inflammatory cells arriving from the blood once individuals reach roughly age 50. While microglia normally clear debris and protect neural tissue, the incoming cells carry heightened inflammatory signals, a shift the authors suggest may underlie the rise in neuroinflammation and neurodegenerative disorders like dementia.

The study also documented deterioration of the blood-brain barrier and extensive changes in DNA methylation and gene expression across the sampled brains. The researchers highlighted that blood-derived cells are more accessible, raising the prospect of modifying them to become less harmful as a new therapeutic avenue for Alzheimer’s and related conditions. Limitations include the small, cross-sectional sample and focus on the hippocampus alone, which may not represent the whole brain. The work was funded by the National Institutes of Health and published in Science.

Why it matters

Understanding the midlife immune shift in the brain could guide new strategies to prevent or treat dementia.

In this story

microgliablood-brain barrierneuroinflammationAlzheimer’s diseasehippocampusimmune cell replacementDNA methylationgene activitymidlife brain changes
Get the beta ↗